Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Matthew Sikora

Concepts (263)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Lobular
11
2026
56
3.520
 Why?
Breast Neoplasms
25
2026
2393
2.600
 Why?
Receptors, Estrogen
10
2025
404
2.270
 Why?
Wnt4 Protein
4
2024
20
1.970
 Why?
Antineoplastic Agents, Hormonal
6
2025
196
1.430
 Why?
Estrogens
7
2025
367
1.360
 Why?
Cell Cycle Proteins
3
2026
630
1.310
 Why?
Adaptor Proteins, Signal Transducing
2
2026
426
1.300
 Why?
Estrogen Receptor alpha
9
2023
151
1.250
 Why?
Drug Resistance, Neoplasm
9
2025
883
0.970
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2026
133
0.950
 Why?
DNA Repair
1
2026
255
0.790
 Why?
Trans-Activators
1
2026
396
0.790
 Why?
Tamoxifen
7
2021
193
0.770
 Why?
Cell Line, Tumor
18
2026
3551
0.750
 Why?
Genital Neoplasms, Female
1
2024
99
0.720
 Why?
Genital Diseases, Female
1
2021
31
0.680
 Why?
Genitalia, Female
1
2021
42
0.670
 Why?
MCF-7 Cells
10
2021
133
0.660
 Why?
Gene Expression Regulation, Neoplastic
12
2025
1450
0.660
 Why?
Nuclear Proteins
1
2026
740
0.660
 Why?
Cell Proliferation
12
2021
2514
0.640
 Why?
Estradiol
7
2023
515
0.630
 Why?
Spinal Curvatures
1
2020
7
0.620
 Why?
Wnt3A Protein
1
2019
11
0.610
 Why?
Acyltransferases
1
2019
78
0.590
 Why?
Psychological Tests
1
2020
130
0.580
 Why?
Ovarian Neoplasms
6
2024
595
0.580
 Why?
Women's Health
1
2021
316
0.570
 Why?
Wnt Signaling Pathway
2
2019
212
0.550
 Why?
Spine
1
2020
182
0.540
 Why?
Clustered Regularly Interspaced Short Palindromic Repeats
1
2017
35
0.510
 Why?
Orthopedic Procedures
1
2020
244
0.510
 Why?
Receptors, Mineralocorticoid
1
2016
11
0.500
 Why?
Anxiety Disorders
1
2020
371
0.490
 Why?
Serum
1
2016
58
0.470
 Why?
Receptors, Androgen
1
2016
149
0.450
 Why?
Signal Transduction
8
2024
5223
0.440
 Why?
Receptors, Glucocorticoid
1
2016
129
0.440
 Why?
Receptors, Progesterone
1
2016
244
0.440
 Why?
Neoplasm Invasiveness
6
2020
508
0.420
 Why?
Aromatase Inhibitors
2
2018
81
0.400
 Why?
Membrane Proteins
1
2019
1166
0.380
 Why?
Phthalazines
2
2026
63
0.370
 Why?
Deep Brain Stimulation
3
2020
220
0.360
 Why?
Tumor Microenvironment
3
2024
735
0.360
 Why?
Cytochrome P-450 CYP2D6
4
2017
32
0.340
 Why?
Gene Expression
2
2014
1478
0.340
 Why?
Female
35
2026
79025
0.330
 Why?
Humans
47
2026
145750
0.320
 Why?
Benzoxazines
1
2010
31
0.320
 Why?
Estrogen Antagonists
1
2010
37
0.320
 Why?
Paraffin Embedding
1
2010
33
0.310
 Why?
Genotyping Techniques
1
2010
71
0.310
 Why?
Risk Assessment
1
2020
3752
0.310
 Why?
Reverse Transcriptase Inhibitors
1
2010
87
0.310
 Why?
Psoriasis
2
2021
115
0.300
 Why?
Androstane-3,17-diol
1
2008
2
0.280
 Why?
Gossypol
1
2008
2
0.280
 Why?
Models, Biological
2
2012
1764
0.260
 Why?
Carcinoma, Ductal, Breast
3
2022
90
0.240
 Why?
Breast
3
2022
156
0.230
 Why?
Receptor, Fibroblast Growth Factor, Type 4
1
2025
2
0.220
 Why?
Xenograft Model Antitumor Assays
2
2026
936
0.210
 Why?
Antioxidants
1
2008
550
0.210
 Why?
Carbonyl Reductase (NADPH)
1
2024
5
0.210
 Why?
Cystadenocarcinoma, Serous
1
2024
89
0.200
 Why?
DNA
1
2010
1437
0.200
 Why?
Neoplasms
2
2010
2913
0.200
 Why?
AMP-Activated Protein Kinases
1
2024
192
0.180
 Why?
Selective Estrogen Receptor Modulators
3
2017
34
0.180
 Why?
Ligands
1
2024
668
0.170
 Why?
Sex Differentiation
1
2021
10
0.170
 Why?
Sexual Development
1
2021
17
0.170
 Why?
Animals
9
2026
38100
0.170
 Why?
Analgesics, Opioid
2
2020
1154
0.170
 Why?
Mammary Glands, Human
1
2021
68
0.160
 Why?
RNA Interference
2
2019
475
0.160
 Why?
Mice
7
2026
18357
0.160
 Why?
Neuroma, Acoustic
1
2021
55
0.160
 Why?
Genotype
3
2017
1857
0.160
 Why?
Protein Binding
2
2016
2240
0.160
 Why?
Cytoreduction Surgical Procedures
1
2020
69
0.150
 Why?
Laminectomy
1
2020
31
0.150
 Why?
Diskectomy
1
2020
24
0.150
 Why?
Uterus
1
2021
228
0.150
 Why?
Cell Survival
2
2016
1103
0.150
 Why?
Culture Media, Conditioned
1
2019
112
0.150
 Why?
Preoperative Period
1
2020
149
0.150
 Why?
Ambulatory Surgical Procedures
1
2020
79
0.150
 Why?
Paracrine Communication
1
2019
67
0.150
 Why?
Snail Family Transcription Factors
1
2019
18
0.150
 Why?
Polymorphism, Single Nucleotide
2
2021
2181
0.150
 Why?
Chemotherapy, Adjuvant
1
2020
427
0.140
 Why?
Coculture Techniques
1
2019
247
0.140
 Why?
Gene Amplification
1
2019
118
0.140
 Why?
Poly(ADP-ribose) Polymerases
1
2019
88
0.140
 Why?
Gene Expression Profiling
2
2018
1777
0.140
 Why?
Clinical Protocols
1
2020
280
0.140
 Why?
Neurosurgical Procedures
1
2020
202
0.140
 Why?
Protein Transport
1
2019
442
0.130
 Why?
Estrogen Receptor Antagonists
1
2017
4
0.130
 Why?
Endometriosis
1
2018
58
0.130
 Why?
Receptors, G-Protein-Coupled
1
2019
231
0.130
 Why?
Transcriptome
2
2021
1043
0.130
 Why?
Neoadjuvant Therapy
1
2020
467
0.130
 Why?
RNA, Small Interfering
1
2019
638
0.130
 Why?
Insulin-Like Growth Factor Binding Protein 3
1
2017
32
0.130
 Why?
Machine Learning
2
2020
587
0.120
 Why?
Middle Aged
11
2024
36297
0.120
 Why?
Fishes
1
2017
110
0.120
 Why?
Dose-Response Relationship, Drug
2
2012
2028
0.120
 Why?
Inflammation
2
2020
2883
0.120
 Why?
Antineoplastic Agents
1
2008
2219
0.120
 Why?
Intracellular Signaling Peptides and Proteins
1
2019
457
0.120
 Why?
Piperazines
1
2019
375
0.120
 Why?
Polymorphism, Genetic
2
2017
615
0.120
 Why?
Promoter Regions, Genetic
1
2021
1247
0.120
 Why?
Androstenes
1
2016
16
0.120
 Why?
Nuclear Receptor Subfamily 4, Group A, Member 1
1
2016
13
0.120
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
106
0.120
 Why?
Surgical Wound Infection
1
2019
329
0.120
 Why?
Proto-Oncogene Proteins
1
2019
625
0.120
 Why?
Cell Culture Techniques
1
2018
375
0.120
 Why?
Neoplasms, Glandular and Epithelial
1
2016
52
0.110
 Why?
Reproduction
1
2017
208
0.110
 Why?
Neoplasm Staging
2
2017
1474
0.110
 Why?
Comorbidity
1
2020
1662
0.110
 Why?
Algorithms
2
2020
1850
0.110
 Why?
Lipid Metabolism
1
2018
529
0.110
 Why?
Prognosis
5
2024
4329
0.100
 Why?
Pilot Projects
1
2020
1897
0.100
 Why?
Pulmonary Disease, Chronic Obstructive
1
2021
920
0.100
 Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2014
58
0.100
 Why?
Retrospective Studies
6
2021
17322
0.100
 Why?
Amyloid beta-Peptides
1
2015
245
0.100
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2020
1969
0.100
 Why?
Aged
7
2024
26212
0.090
 Why?
Biomarkers, Tumor
2
2019
1329
0.090
 Why?
NF-kappa B
1
2016
667
0.090
 Why?
Mutation
2
2021
4090
0.090
 Why?
Neoplasm Recurrence, Local
1
2019
1150
0.090
 Why?
Smoking
1
2019
1477
0.090
 Why?
Phenotype
2
2018
3170
0.090
 Why?
Opioid-Related Disorders
1
2020
605
0.080
 Why?
Quality Improvement
1
2020
1296
0.080
 Why?
Blotting, Western
2
2015
1184
0.080
 Why?
Gynecomastia
1
2010
6
0.080
 Why?
Inhibitory Concentration 50
1
2010
91
0.080
 Why?
Cyclopropanes
1
2010
84
0.080
 Why?
Postoperative Complications
2
2021
2977
0.080
 Why?
Microarray Analysis
1
2010
117
0.080
 Why?
Alkynes
1
2010
67
0.080
 Why?
Formaldehyde
1
2010
65
0.080
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2010
979
0.080
 Why?
Brain Injuries, Traumatic
1
2015
453
0.070
 Why?
Alzheimer Disease
1
2015
630
0.070
 Why?
Polyunsaturated Alkamides
1
2008
7
0.070
 Why?
Cell Cycle Checkpoints
2
2019
97
0.070
 Why?
Estrogen Receptor Modulators
1
2008
14
0.070
 Why?
In Vitro Techniques
1
2010
1049
0.070
 Why?
Genetic Association Studies
1
2010
371
0.070
 Why?
Arachidonic Acids
1
2008
42
0.070
 Why?
Pregnancy
1
2021
7215
0.070
 Why?
Hot Flashes
1
2009
92
0.070
 Why?
Oxidants
1
2008
99
0.070
 Why?
Phosphorylation
1
2012
1708
0.070
 Why?
Treatment Outcome
2
2020
11793
0.060
 Why?
Acetylcysteine
1
2008
139
0.060
 Why?
Drug Synergism
1
2008
354
0.060
 Why?
Heterografts
2
2019
143
0.060
 Why?
Polymerase Chain Reaction
1
2010
1043
0.060
 Why?
Androgens
1
2008
181
0.060
 Why?
Oligonucleotide Array Sequence Analysis
1
2008
751
0.060
 Why?
Cadherins
2
2018
200
0.060
 Why?
Male
6
2020
72992
0.060
 Why?
Protein Kinase Inhibitors
1
2012
981
0.060
 Why?
Reactive Oxygen Species
1
2008
611
0.060
 Why?
Brain
2
2015
2969
0.050
 Why?
Survival Rate
2
2020
2094
0.050
 Why?
Patient Compliance
1
2009
588
0.050
 Why?
Neoplasm Grading
1
2024
311
0.050
 Why?
Patient Discharge
2
2020
995
0.050
 Why?
Cells, Cultured
1
2010
4151
0.050
 Why?
Cell Line
1
2008
2823
0.050
 Why?
Databases, Genetic
1
2023
238
0.040
 Why?
Pancreatic Neoplasms
1
2010
928
0.040
 Why?
Immunohistochemistry
2
2016
1723
0.040
 Why?
Biology
1
2022
89
0.040
 Why?
Microsurgery
1
2021
76
0.040
 Why?
Etanercept
1
2020
60
0.040
 Why?
Ustekinumab
1
2020
17
0.040
 Why?
Adalimumab
1
2020
55
0.040
 Why?
Apoptosis
2
2019
2443
0.040
 Why?
Follow-Up Studies
2
2020
5428
0.040
 Why?
Ubiquitination
1
2020
119
0.040
 Why?
Genetic Predisposition to Disease
1
2009
2399
0.040
 Why?
Proteolysis
1
2020
172
0.040
 Why?
Narcotics
1
2020
58
0.040
 Why?
Adult
5
2021
40867
0.040
 Why?
Movement Disorders
1
2019
69
0.040
 Why?
Oxysterols
1
2018
2
0.040
 Why?
Indazoles
1
2019
85
0.040
 Why?
Postoperative Period
1
2020
351
0.040
 Why?
Adherens Junctions
1
2018
24
0.040
 Why?
Fatty Acid Synthase, Type I
1
2018
11
0.030
 Why?
Morphine
1
2020
169
0.030
 Why?
Sterol Regulatory Element Binding Protein 1
1
2018
56
0.030
 Why?
DNA Copy Number Variations
1
2019
188
0.030
 Why?
Collagen Type I
1
2018
143
0.030
 Why?
Drug Prescriptions
1
2020
288
0.030
 Why?
Piperidines
1
2019
222
0.030
 Why?
Protein Processing, Post-Translational
1
2020
473
0.030
 Why?
Tumor Cells, Cultured
1
2019
887
0.030
 Why?
Combined Modality Therapy
1
2020
1270
0.030
 Why?
Pharmacogenomic Variants
1
2017
35
0.030
 Why?
Cell Adhesion
1
2018
451
0.030
 Why?
Epithelial-Mesenchymal Transition
1
2019
220
0.030
 Why?
Patient Safety
1
2020
356
0.030
 Why?
RNA, Neoplasm
1
2016
83
0.030
 Why?
DNA, Neoplasm
1
2016
160
0.030
 Why?
Risk Factors
2
2020
10916
0.030
 Why?
Tumor Suppressor Protein p53
1
2019
534
0.030
 Why?
Length of Stay
1
2021
1350
0.030
 Why?
Indoles
1
2019
507
0.030
 Why?
Mice, SCID
1
2016
369
0.030
 Why?
Kaplan-Meier Estimate
1
2017
971
0.030
 Why?
Neoplasm Metastasis
1
2017
688
0.030
 Why?
Alleles
1
2017
896
0.030
 Why?
Extracellular Matrix
1
2018
562
0.030
 Why?
Predictive Value of Tests
1
2019
2123
0.030
 Why?
Survival Analysis
1
2017
1378
0.030
 Why?
Cell Movement
1
2018
961
0.030
 Why?
Genome
1
2016
305
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2015
849
0.020
 Why?
Neoplasm Proteins
1
2016
442
0.020
 Why?
Severity of Illness Index
1
2020
2933
0.020
 Why?
Behavior, Animal
1
2015
520
0.020
 Why?
Flow Cytometry
1
2015
1165
0.020
 Why?
Glyceraldehyde-3-Phosphate Dehydrogenases
1
2010
12
0.020
 Why?
Disease Progression
1
2018
2865
0.020
 Why?
Registries
1
2019
2410
0.020
 Why?
Mice, Transgenic
1
2015
2191
0.020
 Why?
Biopsy, Needle
1
2010
185
0.020
 Why?
DNA Primers
1
2010
505
0.020
 Why?
8,11,14-Eicosatrienoic Acid
1
2008
6
0.020
 Why?
Microsomes
1
2008
33
0.020
 Why?
Mice, Nude
1
2010
680
0.020
 Why?
Hydroxylation
1
2008
47
0.020
 Why?
Epoxy Compounds
1
2008
31
0.020
 Why?
Arachidonic Acid
1
2008
102
0.020
 Why?
RNA, Messenger
1
2016
2805
0.020
 Why?
Endocannabinoids
1
2008
56
0.020
 Why?
Mice, Inbred BALB C
1
2010
1261
0.020
 Why?
Base Sequence
1
2010
2171
0.020
 Why?
Disease Models, Animal
1
2015
4569
0.010
 Why?
Mice, Inbred C57BL
1
2015
5992
0.010
 Why?
Young Adult
1
2019
14250
0.010
 Why?
Reproducibility of Results
1
2010
3416
0.010
 Why?
Mitochondria
1
2008
992
0.010
 Why?
Cohort Studies
1
2009
6032
0.010
 Why?
Time Factors
1
2008
7133
0.010
 Why?
Prospective Studies
1
2009
8075
0.010
 Why?
Sikora's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (263) concept(s)
_
Co-Authors Expand Description
See all (28) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)